Cure My Disease

Don't miss your cure!

 Log in / Sign up

New cancer vaccine trial aims to train immune system to fight tumors

NCT ID NCT05329532

Recruiting now Disease control Sponsor: Scancell Ltd Source: ClinicalTrials.gov ↗

Summary

This early-stage study is testing a new cancer vaccine called Modi-1. The goal is to see if it is safe and can help the body's immune system fight advanced forms of breast, head and neck, ovarian, and kidney cancer. Researchers will give the vaccine alone or combined with other approved cancer drugs to about 168 patients to see if it can control the disease.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TRIPLE NEGATIVE BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Addenbrooke's Hospital, Cambridge University Hospitals

    RECRUITING

    Cambridge, United Kingdom

    Contact Phone: •••-•••-••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Belfast City Hospital

    RECRUITING

    Belfast, United Kingdom

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Brighton and Sussex University Hospital

    ACTIVE_NOT_RECRUITING

    Brighton, Default, United Kingdom

  • Christie NHS Foundation Trust

    RECRUITING

    Manchester, Default, United Kingdom

    Contact Email: •••••@•••••

  • Edinburgh Cancer Centre (NHS Lothian)

    RECRUITING

    Edinburgh, Default, United Kingdom

    Contact Email: •••••@•••••

  • Imperial College Healthcare NHS Trust

    ACTIVE_NOT_RECRUITING

    London, Default, United Kingdom

  • Lancashire Teaching Hospitals NHS Foundation Trust

    RECRUITING

    Preston, Default, United Kingdom

    Contact Email: •••••@•••••

  • Mount Vernon

    RECRUITING

    London, Default, United Kingdom

    Contact Email: •••••@•••••

  • Nottingham University Hospitals Cancer Centre

    RECRUITING

    Nottingham, Default, United Kingdom

    Contact Email: •••••@•••••

  • Royal Surrey NHS Foundation

    RECRUITING

    Guildford, Default, United Kingdom

    Contact Email: •••••@•••••

  • Sheffield Teaching Hospital NHS Foundation Trust

    RECRUITING

    Sheffield, Default, United Kingdom

    Contact Email: •••••@•••••

  • The Clatterbridge Cancer Centre NHS Foundation Trust

    RECRUITING

    Liverpool, CH63 4JY, United Kingdom

    Contact Email: •••••@•••••

  • The Royal Marsden NHS Foundation Trust

    NOT_YET_RECRUITING

    Sutton, Default, United Kingdom

    Contact Email: •••••@•••••

  • Torbay and South Devon NHS Foundation Trust

    RECRUITING

    Torquay, United Kingdom

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • University College London Hospital NHS Foundation Trust

    RECRUITING

    London, Default, United Kingdom

    Contact Email: •••••@•••••

  • Velindre Cancer Centre

    RECRUITING

    Cardiff, Default, United Kingdom

    Contact Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

HIGH GRADE OVARIAN SEROUS ADENOCARCINOMA RENAL CELL CANCER SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK TRIPLE NEGATIVE BREAST CANCER